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Human enteroviruses can serve as a more accurate indicator of human fecal contamination than conven-
tional bacteriological fecal indicators. We describe here a quantitative reverse transcriptase PCR (qRT-PCR)
assay specifically tailored to detect these viruses in environmental waters. The assay included a competitive
internal positive control (CIPC) that allowed the inhibition of qRT-PCRs to be quantitatively assessed.
Coamplification of the CIPC with enteroviral genetic material did not affect the sensitivity, specificity, or
reproducibility of the enteroviral qRT-PCR assay. The assay is rapid (less than 5 h from sample to result), has
a wide dynamic range (>3 logs), and is capable of detecting as few as 25 enteroviral genomes with an average
amplification efficiency of 0.91. In samples with low or moderate inhibition, the delay in CIPC amplification
was used to adjust enterovirus qRT-PCR concentrations to account for losses due to inhibition. Samples
exhibiting significant inhibition were not corrected but instead diluted twofold and immediately assayed again.
Using significantly inhibited samples, it was found that dilution relieved inhibition in 93% (25 of 27) of the
samples. In addition, 15% (4 of 27) of these previously negative samples contained enteroviral genomes. The
high-throughput format of the assay compared to conventional culture-based methods offers a fast, reliable,
and specific method for detecting enteroviruses in environmental water samples. The ability of the assay to
identify false negatives and provide improved quantitative assessments of enterovirus concentrations will
facilitate the tracking of human fecal contamination and the assessment of potential public health risk due to
enteroviruses in recreational and shellfish harvesting waters.
Of the enteric viruses, human enteroviruses are one of the
most commonly detected viruses in polluted waters (25). En-
teroviruses are members of the family Picornaviradae and are
estimated to cause 30 million to 50 million infections per year
in the United States, with 30,000 to 50,000 of these resulting in
meningitis hospitalizations (22). Due to viral replication in the
gastrointestinal tract, an infected individual may shed entero-
viruses from the stool for up to 16 weeks (24), with densities as
high as 106 viruses per g of feces (16). Enteroviruses are tol-
erant to residual chlorine from sewage treatment (12) and a
wide range of temperatures and salinities (27, 29), facilitating
their survival in environmental waters. Routine monitoring of
indicator bacteria in environmental waters has demonstrated
weak or nonexistent predictive relationships to enteroviruses
and other human pathogens, suggesting a need for viral patho-
gen-specific assays in environmental waters (8, 9, 19). Given
the load of enteroviruses shed into waters impacted by sewage,
their persistence in environmental waters compared to indica-
tor bacteria, and the role of enteroviruses in waterborne dis-
ease, there is clearly a need for sensitive, quantitative assays for
enteroviruses in environmental samples.
Quantitative reverse transcriptase PCR (qRT-PCR) offers
the potential for fast, reliable, high-throughput analysis of wa-
ter samples for enteroviruses, traits not found with traditional
cell-culture-based detection approaches. Indeed, TaqMan-
based qRT-PCR assays have been developed for the detection
and quantification of viral pathogens from a variety of sources,
including norovirus genogroups I and II from stool and shell-
fish (11); hepatitis A virus (10); and enteroviral loads in cere-
brospinal fluid (17), sludge (18), and natural water samples (4,
6, 9, 23). Despite the fact that these and other successful
PCR-based assays for the detection of enteroviruses have been
developed (see, for example, references 18, 19, 24, 26, and 28),
major hurdles remain for the accurate quantification of viruses
from environmental waters using PCR-based approaches.
One of the primary obstacles to successful PCR-based anal-
ysis is copurification of inhibitory compounds, such as polysac-
charides and humic, fulvic, or tannic acids during RNA isola-
tion from environmental water samples. These compounds
readily inhibit qRT-PCR. Adjuvants such as T34 gene protein,
polyvinylpyrrolidone (PVP), and bovine serum albumin have
been used in the past to reduce PCR inhibition by these com-
pounds (see, for example, references 4, 15, and 18). However,
none have proven fully effective for qRT-PCR. Furthermore,
most of these assays have not included a control that allows
simultaneous assessment of PCR inhibition and enteroviral
concentration.
We present here a rapid, sensitive qRT-PCR assay for quan-
tifying enteroviral concentrations in natural waters that in-
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cludes a competitive internal positive control (CIPC) designed
to quantify qRT-PCR inhibition. This control consisted of
spiking each sample with a synthetic target (CIPC), which was
reverse transcribed and amplified by using the same primers
used in the enteroviral assay. During amplification, the CIPC
was distinguished from enteroviral genomes by using two dif-
ferent fluorescently labeled TaqMan probes specific for each
of the two templates. Adding sufficiently low concentrations of
the CIPC to each sample prevented significant competition for
the primer or nucleotide pools. This allowed unencumbered
detection of enteroviruses over a wide range of concentrations.
Simultaneously, the degree of PCR inhibition was estimated by
the delay in the sample extract CIPC cycle threshold values
relative to uninhibited control reactions. This permitted rapid
identification of samples which required reanalysis after dilu-
tion to reduce inhibition. The CIPC further allowed consistent
normalization of results from one experiment to the next and,
over a certain range of inhibition, corrected estimates of the
number of viral genomes that would have been detected if no
inhibition had occurred.
MATERIALS AND METHODS
Development of the qRT-PCR assay. A TaqMan-based qRT-PCR assay was
developed to detect enteroviral genomes. The assay is based on pan-enteroviral
primers and a TaqMan probe, specific for a 143-nucleotide portion of the 5
untranslated region (5UTR) of poliovirus. This 5UTR region is highly con-
served in the 62 nonpolio enteroviruses and three poliovirus types examined to
date. It is also the target region upon which several other enteroviral RT-PCR
assays have been based (see, for example, references 18, 19, and 24). The
enterovirus (EV)-specific TaqMan probe (Table 1) was labeled with the 5
reporter fluorophore FAM (6-carboxyfluorescien) and the 3 quencher dye
BHQ-1 (black hole quencher 1). After demonstrating no significant difference in
the efficiency of optimized one-step and two-step qRT-PCRs (5), we chose a
one-step, single-tube format using the QIAGEN (Valencia, California) One-
Step RT-PCR kit. Thermal cycling and fluorescence detection were carried out
by using a Cepheid Smart Cycler II (Sunnyvale, Calif.). Reaction conditions
consisted of 1 RT-PCR buffer, 6 mM MgCl2, 500 M deoxynucleoside triphos-
phates (dNTPs), 700 nM primers EV1 F and EV1R (Table 1), 120 nM concen-
trations each of the EV and the competitive internal positive control (CIPC)
probes (Table 1, see CIPC information below), 30 g of bovine serum albumin
(Calbiochem, Bloomington, Ind.), 20 U of recombinant RNasin (Promega, Mad-
ison, Wis.), 1.5% PVP-25 (Sigma Chemical Co., St. Louis, Mo.), 100 copies of the
CIPC template, enteroviral standard or 5 l of extracted RNA from a field
sample, and 1 l of enzyme mix in a final reaction volume of 25 l. A standard
curve was created from serially diluted enteroviral standards and, respectively,
assaying 25, 250, 2,500, or 25,000 copies per reaction. The reverse transcription
was performed for 1 h at 50°C, followed by a 15-min incubation at 95°C for Taq
activation and inactivation of the RT enzymes. Enteroviral cDNA was amplified
by 45 cycles of denaturation (94°C for 15 s) and annealing/extension (60°C for 1
min, with SmartCycler II optics on for fluorescent signal detection).
Real-time fluorescence measurements were recorded on the SmartCycler II
instrument, with the fluorescent thresholds set manually to 5. Cycle thresholds
(CT), the cycle at which sample fluorescence exceeds background fluorescence,
were recorded for the enteroviral standards, CIPC, and RNA from extracted
field samples. The numbers of enteroviral genomes were interpolated from the
standard curve generated from the enteroviral quantification standards versus
their CT. In reactions where the enteroviral CT is lower than the lowest point on
the enteroviral standard curve (25 copies), the concentration of genomes per
reaction is interpolated from a linear regression of the enteroviral standard
curve.
Development of enteroviral quantification standard for the qRT-PCR assay. A
synthetic enteroviral quantification standard for quantifying the number of en-
teroviral genomes in the qRT-PCR assay was constructed by cloning nucleotides
348 to 1218 from the 5 portion of poliovirus Sabin type 1 genome (GenBank
Accession number AY184219) into the pCRII-TOPO T7 vector (Invitrogen,
Carlsbad, Calif.). This 871-bp region encompasses the 143-bp enteroviral qRT-
PCR 5UTR target. Constructing a standard which extended beyond the primer
and probe binding sites was done so that the secondary structure of the standard
RNA transcripts would more closely mimic that found in a wild-type enteroviral
genome than if the enteroviral quantification standard transcript were the same
size as the assay target sequence. The first step in creating the enteroviral
quantification standard involved a two-step qRT-PCR, performed with extracted
poliovirus Sabin type 1 RNA acting as the template for the reverse transcription
and subsequent PCR amplification. OmniScript (QIAGEN) reverse transcrip-
tion reactions consisting of 1 RT-Buffer, 500 M dNTPs, 1 M EV8R (Table
1), 5 U of recombinant RNasin (Promega), and 1 l of OmniScript RT were held
at 37°C for 1 h, followed by a 15-min hold at 95°C. Double-stranded cDNA was
created using 3 l of the RT reaction using 1 PCR buffer, 2.5 mM MgCl2, 500
M dNTPs, 500 nM primers EV6F and EV8R (Table 1), and 1.25 U of Ex Taq
R DNA polymerase (Takara, Madison, Wis.). Thermal cycling was performed on
a Techne Genius thermal cycler (Burlington, N.J.), with an initial denaturation
at 95°C for 3 min, followed by 35 cycles of 95°C for 30 s, 56°C for 45 s, and 72°C
for 3 min, followed in turn by a final extension at 72°C for 7 min. Primers EV6F
and EV8R (Table 1) synthesized by MWG Biotech (High Point, N.C.) were
designed in house to amplify an 871-nucleotide poliovirus amplicon. The PCR
product was visualized through 10 mm of acrylic shielding, under low UV trans-
illumination on a GelDoc 2000 imager (Bio-Rad, Hercules, California) in a
1.2% agarose–1 TAE gel containing 500 ng of ethidium bromide per ml. The
871-bp band was excised, gel purified using Wizard SV gel and PCR clean up
system (Promega), TOPO TA cloned into a pCR II-TOPO T7 vector (Invitro-
gen), and transformed into One-Shot TOP10 (Invitrogen) chemically competent
Escherichia coli according to the manufacturer’s instructions. Transformed col-
onies were screened for correct insertion and orientation of the enteroviral
product, through a PCR utilizing primer M13 forward and the internal entero-
viral primer EV1R (Table 1). Plasmid DNA was isolated from positive clones
using a PerfectPrep Plasmid Minikit (Eppendorf, Westbury, Conn.) and se-
quenced bidirectionally to confirm that the sequence and insertion of the 871-bp
enteroviral 5UTR construct was correct.
Enteroviral quantification standards were created by in vitro transcription of
BamHI (New England Biolabs, Ipswich, Mass.)-linearized plasmid DNA by using
a MAXIscript In Vitro T7 Transcription Kit (Ambion, Austin, Tex.). Transcripts
were treated with DNase I (Ambion) and purified by using a MEGAclear RNA
purification kit (Ambion). Transcript integrity was confirmed by electrophoresis
for 15 min at 100 V in a 0.65% agarose–1 TAE (Tris-Acetate EDTA) gel
containing 500 ng of ethidium bromide per ml and visualized under UV transil-
lumination. The transcripts appeared as a concise band of the appropriate size on
the gel, indicating that no significant degradation had occurred. Transcripts were
quantified fluorometrically by using RiboGreen (Molecular Probes, Eugene,
Oreg.). The enteroviral quantification standard was diluted to 105 copies l1
and stored in single-use aliquots at 80°C. Given that enteroviruses carry one
5UTR target per genome (24), it is assumed that one enteroviral quantification
standard transcript is equivalent to a single enteroviral genome.
Development of the CIPC. For our enteroviral qRT-PCR, a CIPC was created
to assess inhibition, using the approach described by Kleiboeker (13). In brief,
hybrid primers were constructed and designated EV1F T7 comp and EV1R
comp. EV1F T7 comp contained, in 5-to-3 order, the sequence for the T7 RNA
TABLE 1. Primer and probe sequences


















a Sequences modified or taken directly from Kleiboeker (13); portions homol-
ogous to the plasmid vector are in italics, sequences homologous to enteroviral
primer sequences (EV1F and EV1R respectively) are shown in boldface, and the
T7 RNA polymerase promoter is shown in bold italics.
b Sequences provided by G. Shay Fout (U.S. Environmental Protecction
Agency, NERL, Cincinnati, Ohio).
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polymerase promoter site, the enteroviral forward primer EV1F, and 17 bp
homologous to bp 477 to 493 in the pCRII-TOPO T7 vector. EV1R comp
contained from 5 to 3 the reverse enteroviral primer EV1R and 17 bp homol-
ogous to bp 403 to 419 in the vector (Table 1). These hybrid primers were used
to amplify a 91-bp fragment of the TOPO vector flanked by the combined
T7-EV1F sequence at the 5 end and the EV1R sequence at the 3 end. The
amplification conditions were identical to those outlined by Kleiboeker (13). The
resulting PCR product was run out on a 2% agarose–1 TAE gel containing 500
ng of ethidium bromide per ml. The expected 152-bp product was excised from
the gel under low UV illumination on a GelDoc 2000 imager (Bio-Rad) and
purified by using a Wizard SV gel and PCR clean-up system (Promega). Purified
CIPC template DNA was transcribed at 37°C for 1 h, using a MAXIscript In
Vitro T7 Transcription Kit (Ambion), yielding a 131-nucleotide transcript. The
resulting RNA was purified (MEGAclear RNA Purification Kit; Ambion) and
quantified fluorometrically as described for the enteroviral standard. Transcript
integrity was confirmed by electrophoresis of the CIPC for 15 min at 100 V in a
2% agarose–1 TAE (Tris-acetate EDTA) gel containing 500 ng of ethidium
bromide per ml and visualized under UV transillumination. The CIPC tran-
scripts formed a concise band of appropriate size on the gel, indicating that no
significant degradation had occurred. CIPC transcripts were stored in single-use
aliquots at 80°C at concentrations of 104 copies l1.
Incorporation of the enteroviral primers sites allowed amplification of both the
CIPC and the enteroviral templates using the same enteroviral primers, EV1F
and EV1R. The CIPC was discriminated from enterovirus by using the CIPC
TaqMan probe, which corresponded to bp 436 to 461 of the pCRII-TOPO T7
vector. The probe was labeled with the 5 reporter fluorophore Cy5 and the 3
quencher dye BHQ-2 (black hole quencher 2). Further, the 126-bp CIPC and
143-bp enteroviral qRT-PCR products can be distinguished from each other by
using polyacrylamide gel electrophoresis, ethidium bromide staining, and UV
transillumination.
The CIPC was sequenced to ensure the integrity of the T7 RNA polymerase
promoter site, the primer binding sites, and the internal vector sequence. This
was accomplished by performing the reverse enteroviral qRT-PCR assay using
CIPC transcripts with an additional 10-min 72°C final extension step. The re-
sulting qRT-PCR product was purified by using a Wizard SV gel and PCR
clean-up system (Promega), sequenced bidirectionally by MWG Biotech, Inc.,
and revealed the expected sequence. A BLAST search using this sequence
revealed no homologues with naturally occurring sequences in GenBank (1, 2).
Analysis of the CIPC and enteroviral amplicons using the JaMBW Chapter 3.1.9
Oligo Calculator (3) revealed that the GC contents of the CIPC amplicon (53%)
and enteroviral amplicons (54%) were nearly identical.
The difference between the average CT in the control samples and in the field
samples was used to estimate the degree of PCR inhibition and for correcting the
enteroviral estimates. Specifically, the CT value was calculated by subtracting
the mean CIPC CT value for the uninhibited control reactions from the sample
CIPC CT. The CT value is applied in the equation (E  1)CIPC CT, where E is
the amplification efficiency calculated from the enteroviral standard curve using
the equation: E 	 [10(1/slope)]  1. This calculation provides an estimate for
each qRT-PCR of the constant by which the corresponding enteroviral estimate
must be multiplied in order to reflect the actual number of enteroviral copies that
would have been obtained if no inhibition had occurred. This CIPC approach is
similar to that described by Haugland et al. (7).
Samples in which the CIPC failed to amplify or amplified later than 3.7 cycles
(equal to an 
1-log decrease in the qRT-PCR amplification relative to the
control) greater than the average CT of 34.6 value were considered either too
inhibited for reliable quantification of enteroviral concentrations or potentially
negative. To distinguish between these two possibilities, these samples were
diluted to half-strength with molecular-grade RNase-free water and reanalyzed.
Diluted samples with a CIPC delay of 3.7 cycles more than the control and that
still showed no enteroviral amplification were scored as having an enteroviral
concentration below the limit of detection (i.e., negative). Diluted samples with
a CIPC delay of 3.7 cycles and for which an enteroviral concentration could
then be estimated were corrected as described above using the CIPC CT
method with the inclusion of 1:2 dilution factor.
Optimizing the assay. The optimal concentration of CIPC to incorporate into
the qRT-PCR assay was determined empirically by adding either 0, 10, 100, or
1,000 copies of the CIPC to reactions containing serially diluted enteroviral
quantification standards consisting of 25, 250, 2,500, and 25,000 copies. The
amplification efficiency and sensitivity of these standard curves was compared.
The goal was to determine a CIPC concentration that amplified consistently but
that did not affect the efficiency or sensitivity of enteroviral amplification over a
broad range of enteroviral concentrations. Once the optimized concentration of
the CIPC standard was determined, the consistency between enteroviral stan-
dard curves incorporating the CIPC control was evaluated. This was done by
determining the slope and efficiency statistics from nine individual standard
curves and calculating the mean and standard deviation for both parameters. The
relationship between assay variability and enteroviral concentration was evalu-
ated by plotting the standard deviation in CT values at each enteroviral quanti-
fication standard concentration from the same nine standard curves.
Evaluating the effectiveness of the CIPC correction factor using spiked sam-
ples. We examined the effectiveness of the CIPC at identifying qRT-PCR inhi-
bition, as well as acting as a calibrator for enteroviral concentration. Ten-liter
grab samples were collected from the Rachel Carson Estuarine Research Re-
serve in Beaufort, N.C., and transported back to the laboratory on ice in the dark
on 10 May 2005. Of these samples, the one from Deep Creek water exhibited the
highest degree of turbidity (16 nephelometric turbidity units). The sample was
highly colored, indicating the sample’s complexity and presumably high levels of
humic acids, sediment, and other environmental qRT-PCR inhibitors. This high-
turbidity sample was selected for testing the inhibition assay because is was likely
to represent a worst-case scenario for the carryover of compounds inhibitory to
the qRT-PCR after filtration and extraction.
For the study, 100-, 250-, and 400-ml aliquots were filtered in duplicate though
0.45-m-pore-size nitrocellulose type HA filters (Millipore). At 400 ml, the filter
became clogged, and no more sample could be passed. All filters appeared dark
brown after filtration. RNA was extracted and eluted with 50 l of RNase-free
water as described by Noble et al. (21). The standard enteroviral qRT-PCR was
performed on each of the extracts described above. These assays showed that the
native enteroviral concentrations in the samples were below detection limits. The
RNA extracts were again assayed, allowing further assessment of the CIPC’s
effectiveness as a calibrator. For each sample, 5 l of RNA extract was added to
20 l of qRT-PCR master mix prepared with 1,000 copies of the enteroviral
quantification standard and 100 copies of the CIPC added. Each RNA extract
was then assayed by using the standard qRT-PCR assay conditions, along with
equivalent control reactions containing no sample RNA or a negative extraction
control. A conventional enteroviral standard curve was also run. The control
reactions (no sample RNA and the negative extraction control) were used to
determine the average CIPC CT of uninhibited reactions. The CIPC CT of each
sample relative to the control reactions was calculated and used to estimate the
true number of viral genomes present (n) in each reaction as follows: enteroviral
standard curve  (E  1)CIPC CT 	 n.
Use of the CIPC correction factor to estimate enteroviral concentrations in
samples exhibiting significant inhibition. The ability of the CIPC to identify
inhibited samples and allow detection of enteroviral genomes in diluted aliquots
of these samples was evaluated using environmental water samples from Ballona
Creek, Calif. These field samples were collected and filtered as described by
Fuhrman et al. (4). RNA was extracted from the field samples as described in
Noble et al. (21). A total of 59 samples were available for processing during this
study. Samples were analyzed by our qRT-PCR assay and were considered to be
significantly inhibited if the CIPC CT of each sample for a sample was 3.7. A
reduction of 3.7 cycles corresponds to an 
1-log reduction in amplification based
on the cumulative enteroviral qRT-PCR efficiency of 0.92. Samples that exhib-
ited no amplification of the CIPC, within the 45 cycles of the qRT-PCR, which
corresponds to 11 cycles beyond the average CIPC CT, were considered com-
pletely inhibited. Based on these criteria, 36 of the original 59 samples were
inhibited. To further investigate a strategy for dealing with inhibited samples, 27
of the inhibited samples were diluted 1:2 with molecular-grade RNase-free water
and reanalyzed by using the standard qRT-PCR assay.
Estimating the minimum detection limits in PFU for the echovirus 12 stock.
To address the qRT-PCR assay sensitivity from a public health standpoint, the
relationship between enteroviral genomes (determined by the qRT-PCR) and
enteroviral particles (determined by epifluorescence microscopy) was related to
infectious units in the following manner. A stock of a model enterovirus, echo-
virus 12, was obtained from the laboratory of Mark Sobsey at the University of
North Carolina at Chapel Hill. The stock was propagated and plaque assayed
using FRhK-4 cells and had a titer of 1.23  109 PFU ml1. The concentration
of viral particles in an aliquot of the titered stock was determined by using
epifluorescence microscopy as described in Noble and Fuhrman (20). Briefly,
echovirus 12 was diluted, fixed with 0.02-m-pore-size-filtered 5% formalin (final
concentration), and filtered onto 0.02-m-pore-size Anodisc 25 membrane filters
(Whatman, Florham Park, N.J.). Filters were stained by using SYBR Green I
nucleic acid stain (Molecular Probes) and mounted on glass slides. Slides were
observed on a Nikon Eclipse E800 (Nikon, Inc., Melville, N.Y.) microscope,
at 1,000 magnification, using blue excitation, with 10 random fields of virus
particles enumerated, yielding a calculation of viral particles that could be com-
pared to the original titer (in PFU) of the echovirus stock. Subsequently, the
number of genome equivalents per particle was estimated by carefully diluting
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the echovirus stock so that there were either 109, 108, or 107 particles per 700-l
aliquot of freshly prepared RLT RNA extraction buffer (QIAGEN). At the same
time, a standard curve was constructed by adding either 109, 108, or 107 entero-
viral quantification standard transcripts to identical 700-l aliquots of RLT RNA
extraction buffer. Triplicate samples of both the viral particles and the entero-
viral quantification standard transcripts from each dilution were extracted by
using a QIAGEN RNeasy minikit according to the manufacturer’s instructions.
Final elutions to 50 l were made by using RNase-free molecular-grade water.
Then, 2 l of the extracted RNA from each sample was assayed by using the
enteroviral qRT-PCR. By extracting both the echovirus particles and the entero-
viral standard transcripts in the same manner, it was possible to normalize for
any losses taking place during the extraction process, thus assuring that echoviral
particles and enteroviral quantification standards were subject to the same con-
ditions prior to qRT-PCR analysis.
These data provided an estimate of both the number of viral particles PFU1
and number of enteroviral quantification standard transcripts PFU1. These two
estimates were used to calculate potential limits of detection in PFU for echo-
virus 12 as follows. For the viral particle counts it was assumed that each particle
carried a single RNA genome and that each genome contained one enteroviral
target sequence corresponding to one enteroviral quantification standard tran-
script. Given these assumptions, a lower limit of detection could be determined
by dividing the minimum detectable level of enteroviral quantification standard,
determined empirically for the assay, by the number of viral particles PFU1.
This estimate likely represented a “worst-case” estimate for the limits of detec-
tion because evidence suggests that the SYBR Green I staining method used may
underestimate the true number of viral particles present in a sample, especially
when enumerating RNA viruses. Alternatively, the same calculation was done
using the direct qRT-PCR estimates of the number of enteroviral genomes
PFU1, which are again equivalent to enteroviral quantification standard tran-
scripts, instead of the number of viral particles PFU1. This calculation likely
represented a “best-case” estimate of the sensitivity due to the fact that it would
measure any unpackaged viral genomes released during infection, in addition to
intact and potentially infectious virus.
RESULTS
The reaction conditions for coamplification of the enterovi-
ral quantification standard and the CIPC were determined
after optimization of the reaction conditions as monoplex as-
says. Primers, probes, and nucleotide concentrations were var-
ied factorially along with CIPC concentrations ranging from 10
to 1,000 transcripts per reaction. Through this analysis, we
determined that 100 copies of the CIPC template per reaction
permitted consistent amplification over a broad range of target
enteroviral genomes without decreasing the sensitivity or re-
producibility of the qRT-PCR (Fig. 1 and 2). As enteroviral
genomes concentrations approach 25,000, however, the CIPC
failed to amplify in one-third of the samples (three of nine) due
to increased competition for nucleotides and primers.
Results compiled from a total of 88 qRT-PCRs demon-
strated that the average CT for 100 copies of the CIPC was 34.7
(1.1). For comparison, in the no-template-control reactions,
where there was no competition with the enteroviral standard,
the average CIPC CT was 34.2 (0.5, Fig. 2). Preliminary
experiments using 1,000 CIPC copies per reaction caused a
truncation in the dynamic range of the enteroviral standard
assay, whereas 10 copies per reaction failed to amplify consis-
tently, making it impossible to distinguish true inhibition from
nonamplification (data not shown).
The amplification efficiency and slopes of the enteroviral
standard curve with or without the CIPC additions were not
statistically different (P  0.05, Fig. 3 [as determined by anal-
ysis of variance]). The CIPC did not appear to reduce the
sensitivity or reproducibility of enteroviral standard detection.
The results from 86 reactions (nine enteroviral standard
curves), compiled into one cumulative enteroviral standard
curve show high linearity with an average qRT-PCR amplifi-
cation efficiency of 0.91 (0.18, Fig. 4).
The dynamic range of our qRT-PCR assay is wide (3 logs),
ranging from 25 to 25,000 copies of the enteroviral standard
(Fig. 3). However, at less than 250 copies the assay variability
increases, with an overall average amplification failure at 25
enteroviral copies of 22%. This variability is indicated by the
larger standard deviations in the enteroviral CT values as the
concentration of the enteroviral standards decreases (Fig. 4).
Consequently, all standards were run in triplicate.
Results from the inhibition assay indicate that all of the
extracted RNA samples possessed some level of qRT-PCR
inhibitors present in the extracted RNA. As filtration volumes
FIG. 1. Detection of the competitive internal positive control (100
copies), along with various concentrations (25 to 25,000 copies) of
enteroviral quantification standards run in triplicate, to generate the
standard curve used in our analysis of field samples. Enteroviral quan-
tification standard transcripts are denoted with a “}” symbol, while
CIPC transcripts are denoted with a “■ ” symbol. CIPC CT remains
constant across a broad range of enteroviral standards. One of the
CIPC samples failed to amplify in the presence of 25,000 copies of
enteroviral standards. The amplification efficiency was calculated from
the slope of the linear regression.
FIG. 2. Variation in CIPC CT with various concentrations of en-
teroviral quantification standards ranging from 0 copies in the no-
template control (ntc) to 25,000 copies. The average CIPC CT is noted
in boldface, with error bars representing 1 standard deviation. At the
highest enteroviral quantification standard concentration (25,000 cop-
ies), the CIPC failed to amplify in one-third of the samples (three of
nine).
VOL. 72, 2006 ENTEROVIRAL qRT-PCR WITH INTERNAL CONTROL 3963
increased, so did the capture of inhibitory compounds, which
resulted in a significantly reduced enteroviral standard detec-
tion (Table 2). The use of the CIPC as a calibrator reduced the
effects of the inhibitors on enteroviral quantification and al-
lowed a relatively accurate assessment of the level of entero-
viral contamination in a given sample (75%) despite the
presence of inhibitors (Table 2).
Minimum detection limits in PFU for the echovirus 12
stock. The titered echovirus 12 stock yielded an estimate of 102
(11) detectable echovirus particles PFU1 using the SYBR
Green I method and 326 enteroviral quantification standard
transcripts PFU1 using qRT-PCR. These translate into lower
limits of detection of 0.25 and 0.08 PFU based on the echovirus
and enteroviral standard estimates using the lower limit of
detection for the enteroviral qRT-PCR assay of 25 enteroviral
transcripts. These data also indicate 3.2 (0.7) genomes per
stainable echovirus particle, which is higher than the expected
1:1 ratio based on the fact that enteroviruses contain one
genome per virion.
Analysis of field samples. Upon reanalysis of the inhibited
California field samples, 4 of the 27 (14.8%) samples were
shown to contain amplifiable enteroviral genetic material,
with concentrations ranging from 193 to 5.193 genomes li-
ter1 (Table 3). Two of the extracts remained inhibited at this
dilution—one completely and one partially (Table 3).
DISCUSSION
The qRT-PCR assay developed in this study can detect a
broad range of human enteroviruses and can be used to detect
human fecal contamination in environmental water samples.
The assay is rapid and sensitive and allows a realistic assess-
ment of PCR inhibition, an important feature for assays of
real-world samples. It can be completed in less than 5 h from
the sample to the result and is capable of detecting as few as 25
enteroviral genomes (Fig. 1 to 4). The assay can be used to
screen recreational and shellfish-harvesting waters for human
fecal contamination, thereby providing public health officials
with a reliable assessment of the potential health risks associ-
ated with using these waters for recreation or shellfishing.
One of the primary obstacles in developing qRT-PCR viral
assays of this type for screening environmental samples is the
isolation of inhibitors along with RNA during the extraction
process. This has led to the use of adjuvants, such as PVP (14,
18), in the extraction process. The PVP binds various inhibitors
and is easily separated during the RNA extraction process,
helping prevent carryover of the inhibitors (2). Bovine serum
albumin (15) and PVP have also been added directly to qRT-
PCRs to bind inhibitors, thereby preventing them from inter-
fering with the RT and DNA polymerase enzymes. Although
these and other techniques have allowed significant progress in
reducing the purification and suppressive effects of inhibitory
compounds, the problem of inhibitors has not been eliminated.
This necessitates the incorporation of an internal control to
monitor inhibition. Otherwise, qRT-PCRs that failed due to
inhibition cannot be distinguished from samples where viral
loads were below the limits of detection. Protocols utilizing
internal controls to monitor RT-PCR inhibition have been
developed for enteroviral detection in clinical settings (17), but
few have been developed for use in the amplification of envi-
ronmental samples (23).
FIG. 3. Comparison of individual enteroviral standard curves with
CIPC (■ ) or without CIPC (}), demonstrating consistency among
standard curves. The amplification efficiencies were calculated from
the slopes of the linear regressions.
FIG. 4. (A) Cumulative enteroviral standard curve compiled from
86 reactions (nine individual enteroviral standard curves), amplified
with the CIPC. The amplification efficiency was calculated from the
slope of the linear regression. (B) Variability according to enteroviral
quantification standard concentration is shown by plotting enteroviral
qRT-PCR CT as a function of concentration of enteroviral quantifica-
tion standards. One standard deviation in CT is represented by each
point (}) for the given log-transformed enteroviral quantification stan-
dard concentration.
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The assay developed in the present study incorporated a
CIPC in each sample to assess inhibition. The CIPC contained
the same conserved primers sites as utilized for amplifying the
target enteroviral sequence, and a sequence of similar size and
composition to the target enteroviral template (CIPC ampli-
con [53% GC] and enteroviral amplicon [54% GC]). Amplifi-
cation of the CIPC and enteroviral templates was distinguished
by utilizing a different TaqMan probe specific to each tem-
plate. Assay development further required an empirical deter-
mination of the minimal CIPC concentration that produced a
consistent amplification without significantly reducing the sen-
sitivity, specificity, or reproducibility of the enteroviral assay.
Preliminary studies showed that 100 CIPC copies per reaction
amplified reliably at a CT of between 34.5 and 35.0 over a range
of 25 to 25,000 standard enteroviral transcripts per reaction
(Fig. 1 and 2). At high enteroviral transcript concentrations
(e.g., 25,000 enteroviral transcripts per reaction), however,
the CIPC failed to amplify in 33% of the samples. These CIPC
failures were probably due to competition between the CIPC
and enteroviral quantification standard for nucleotides and
primers in the qRT-PCRs. When analyzing field samples, these
CIPC failures are likely to be rare because reported environ-
mental enteroviral RNA concentrations measured to date fall
far below the levels that would cause a problem (see, for
example, references 4, 9, and 21). If samples with enteroviral
transcripts per reaction above 20,000 to 25,000 were to be
encountered, they should be diluted and reanalyzed to ensure
accurate enteroviral estimates, or the researcher can choose to
reoptimize the CIPC concentration for use with higher con-
centrations of target.
The ability of the CIPC to identify inhibited samples was
also readily demonstrated in a recent field study where, despite
careful extraction procedures, 61% of the qRT-PCRs using
this assay were found to be significantly inhibited (21). In the
present study, we used a subset (n 	 27) of the inhibited
samples to investigated whether a simple 1:2 dilution of with
RNase-free water would reduce the PCR inhibition sufficiently
for reliable enteroviral estimates to be obtained. Upon reanal-
ysis, 4 of the diluted samples contained measurable concentra-
tions of enteroviruses, and 21 were negative for enteroviruses,
but no longer showed significant inhibition. This demonstrated
the utility of using the CIPC and simple dilution methods to
identify inhibited samples and to differentiate false negatives
from samples with enteroviral concentrations below assay de-
tection levels.
Within limits, the CIPC can also be used to successfully
correct enteroviral estimates obtained from partially inhibited



























100 ml 33.52 36.16 191 317 29.9 1.57 859 81.0
100 ml 32.20 36.19 442
250 ml 34.84 38.40 83 139 13.1 2.75 796 75.1
250 ml 33.50 36.31 194
400 ml 35.36 39.79 60 84 7.9 3.81b 943 89.0
400 ml 34.42 37.04 108
No extract 30.78 34.07 1,086 1,060 100.0 1,060
No extract 30.86 35.14 1,033
Avg CIPC CT neg controls 34.61
a A total of 1,000 copies of the enteroviral quantification standard and 100 copies of the CIPC were added directly to the qRT-PCR master mix. Enteroviral
concentrations were calculated by using the enteroviral standard curve with or without the CIPC CT calculation. Control reaction mixtures containing none of the
extract from the Deep Creek samples were run in parallel to estimate the accuracy of the enteroviral assay. neg, negative.
b Under normal circumstances, this sample would have met the criteria for inhibition and would have been diluted and reanalyzed.
TABLE 3. Results from Ballona Creek, Calif., field samples
analyzed with the enteroviral qRT-PCRa
Field
sample
Initial analysis Postdilution analysis






8 11 1:2 1.2 0 0
9 11 1:2 0.88 0 0
13 11 1:2 1.11 0 0
19 11 1:2 1.6 0 0
20 11 1:2 1.05 0 0
21 11 1:2 2.13 0 0
23 11 1:2 0.59 0 0
28 11 1:2 1.57 1,641 4,507
29 11 1:2 3.41 579 5,193
30 11 1:2 1.67 0 0
31 11 1:2 0.66 0 0
32 11 1:2 0.75 0 0
33 11 1:2 2.95 0 0
34 11 1:2 3.92b 0 0
39 9.48 1:2 3.34 0 0
41 10.07 1:2 3.21 0 0
43 11 1:2 2.55 0 0
44 4.92 1:2 0.46 0 0
45 11 1:2 11c 0 0
46 11 1:2 1.79 61 193
47 11 1:2 1.02 0 0
48 11 1:2 2.71 384 2,193
51 11 1:2 1.1 0 0
53 11 1:2 1.11 0 0
54 11 1:2 0.87 0 0
58 11 1:2 1.5 0 0
59 6.81 1:2 3.25 0 0
a Inhibition was determined by subtracting the average CIPC CT (34.6) from
the sample CIPC CT. Samples in which the CIPC was less than 3.7 CT were
considered not to have inhibition, and genome concentrations were adjusted
using the CIPC CT as a calibrator. Samples with a CIPC CT of between 3.7
and 11 were considered partially inhibited, and samples with CIPC CT values of
11 were considered completely inhibited. In samples positive for enterovirus,
the genomes liter1 were determined by using the calculated genomes reac-
tion1 extrapolated to the total volume analyzed, taking into account dilution
and scaling the number up to 1 liter.
b Sample still partially inhibited after dilution.
c Sample still completely inhibited after dilution.
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qRT-PCR samples. This is accomplished by using the differ-
ence in CIPC CT values between control and field samples, in
conjunction with the qRT-PCR amplification efficiency, to cal-
culate the fold reduction in the CIPC for each sample. The
CIPC fold reduction for each sample is then used to correct the
actual enteroviral estimate to that which would have been
obtained if no inhibition had occurred. Reasonable enteroviral
concentrations can then be back-calculated for samples show-
ing up to 
90% inhibition (CIPC CT of 
3.7). Employing
this method, we were able to adjust enteroviral concentrations,
in our spiked samples, to within 75% of their expected values
(Table 2).
Although the dilution scheme worked in most cases to elim-
inate inhibition (Table 3), it has the obvious disadvantage that,
at very low enteroviral levels, the chance exists that the dilution
itself will take the sample below levels of detection. With small
dilutions, such as those used in the present study, the chance of
losing signal solely on the basis of dilution is minimized. Op-
timally, improvements in viral filtration and RNA extraction
methods will reduce qRT-PCR inhibitor levels in reactions, but
without adequate internal controls for the qRT-PCR the ef-
fectiveness of these new methods cannot be validated.
The data obtained in validating this assay indicate that as the
enteroviral loads decrease, assay variability increases dramat-
ically (Fig. 4). Given these data, it would be logical to assume
that the best strategy would be to filter more environmental
sample to obtain higher viral concentrations in order to reduce
assay variability. This approach, however, proved counterpro-
ductive. For sample sizes greater than 250 to 500 ml, the
increased coisolation of inhibitors completely negated any
gains in amplification efficiency that was achieved by isolating
a higher concentration of viral genomes (Table 2). By reducing
filtration volumes, the capture of inhibitory compounds can be
minimized, improving the RNA extraction and subsequent
qRT-PCR and, through the use of the CIPC as a calibrator,
any effects from inhibition can be effectively corrected for.
Future improvements in eliminating elements inhibitory to the
qRT-PCR or in selectively removing viral genomes from bulk
samples will be required before large-volume samples from
most recreational waters can be quantitatively assayed. In the
interim, accurate estimates of low enteroviral concentration
(50 genome equivalents per sample) will require analysis of
multiple replicates per sample.
Relating results obtained from qRT-PCR assays to levels of
infectious virus is vital for the assessment of public health risk
and epidemiological models. Any detection of enteroviral ge-
netic material is indicative of the presence of enteroviruses, but
the actual abundance of infectious enteroviral particles is
harder to elucidate. Previously, PFU have been used as a
measure of infectious particles, but it is likely that a PFU
greatly underestimates the number of actual infectious virions
in a sample because of the inherent nature of PFU-based
assays. In the present study, we estimated that the lower limit
of detection for the qRT-PCR assay was somewhere between
0.08 and 0.25 PFU for echovirus 12. Although this lower range
of sensitivity is likely to vary from enterovirus to enterovirus
and from host to host, the echovirus 12 results demonstrate
that the assay is capable of measuring clinically relevant levels
of enteroviruses in environmental samples.
Accurate quantification of human enteroviral genomes in
environmental waters is necessary to assess potential public
health risk associated with water contact and also for tracking
the sources of human fecal contamination (21). The enterovi-
ral qRT-PCR assay developed in the present study is rapid and
can be applied to any study requiring accurate quantification of
enteroviruses in environmental samples. The dynamic range of
the assay was 3 logs, from 25 to 25,000 genome equivalents. As
with any PCR-based assay for viral pathogens, it is limited by
only being able to detect genomes rather than to directly assess
infectivity. However, control studies with echovirus 12 virus
indicate that, while not measuring infectivity directly, the assay
sensitivity does allow clinically relevant levels of enteroviruses
(in the 0.08- to 0.25-PFU range) to be detected. The assay
incorporated a CIPC that allowed rapid identification of in-
hibited samples. In a majority of cases, inhibition was reduced
sufficiently by diluting samples, so that false negatives could be
distinguished from samples with enteroviral concentrations be-
low detection levels. The CIPC was also used to estimate
correction factors for enteroviral estimates obtained from par-
tially inhibited samples, thereby allowing improved estimates
of enteroviral loads in complex environmental water samples.
The improved accuracy provided by the CIPC represents a
major advancement in the field. Application of this assay will
make it possible to accurately assess enteroviral loads in both
recreational and shellfish-harvesting waters, hopefully provid-
ing improved means for management and restoration of these
resources.
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